Recombinant Equine Interleukin-1 Receptor Antagonist Protein ( Equine IL-1RA)-细胞/细菌培养-试剂-生物在线
翌圣生物科技(上海)股份有限公司
Recombinant Equine Interleukin-1 Receptor Antagonist Protein ( Equine IL-1RA)

Recombinant Equine Interleukin-1 Receptor Antagonist Protein ( Equine IL-1RA)

商家询价

产品名称: Recombinant Equine Interleukin-1 Receptor Antagonist Protein ( Equine IL-1RA)

英文名称: Recombinant Equine Interleukin-1 Receptor Antagonist Protein ( Equine IL-1RA)

产品编号: 90185ES08

产品价格: 0

产品产地: Yeasen

品牌商标: Yeasen

更新时间: 2023-08-17T13:40:59

使用范围: null

翌圣生物科技(上海)股份有限公司
  • 联系人 : 李自转
  • 地址 : 上海市浦东新区天雄路166弄一号楼三层南单元
  • 邮编 : 200030
  • 所在区域 : 上海
  • 电话 : 139****5640 点击查看
  • 传真 : 点击查看
  • 邮箱 : lizizhuan@yeasen.com
  • 二维码 : 点击查看

 

  • Product Information

     

    Product Name

    Cat#

    Size

    Price¥

    Recombinant Equine Interleukin-1 Receptor Antagonist Protein ( Equine IL-1RA)

    90185ES08

    5 μg

    815

    90185ES60

    100 μg

    5,645

    90185ES76

    500 μg

    14,865

     

    Product Description

     

    Secreted equine IL-1 receptor antagonist (IL-1ra) is a presumably 22-25 kDa glycoprotein produced by variety of cell types that antagonizes IL-1 activity. It is a member of the IL-1 family of proteins that includes IL-1 alpha and IL-1 beta. Although there is little amino acid (aa) identity (< 30%) among the three IL-1 family members, all molecules bind to the same receptors, all show a beta -trefoil structure, and all are believed to have evolved from a common ancestral gene. Equine IL-1ra is synthesized as a 177 aa precursor that contains a 25 aa signal sequence plus a 152 aa mature region. There is one intrachain disulfide bond and one potential N-linked glycosylation site. Mature equine sIL-1ra is 78%, 78%, 80%, 82%, and 76% aa identical to mature mouse, human, porcine, canine and bovine IL-1ra, respectively. In human, three non-secreted IL-1ra isoforms have also been identified. It is unknown if such an analogous situation exists in equine. Cells known to secrete IL-1ra include fibroblasts, vascular smooth muscle cells, intestinal columnar epithelium, chondrocytes, macrophages, mast cells, neutrophils and hepatocytes. There are two type I transmembrane glycoprotein receptors for IL-1ra. The first is the bioactive 80 kDa type I IL-1 receptor (IL-1 RI), and the second is the inert (decoy) 65 kDa type II IL-1 receptor. IL-1ra binding to IL-1 RI competitively blocks IL-1 ( alpha or beta ) binding to the same receptor. This results in receptor ligation without activation. The type II IL-1 receptor is inert, and any binding of IL-1ra not only fails to block co-existing IL-1 activity, but may actually potentiate it by removing an IL-1 antagonist. Functionally, all activities attributed to IL-1ra are explained by its role as a competitive inhibitor of IL-1 binding to IL-1 RI.

     

    Product Properties

     

    Synonyms

    IL-1RN, IRAP

    Accession

    O18999

    GeneID

    100034236

    Source

    E.coli-derived Equine IL-1RA, His26-Gln177.

    Molecular Weight

    Approximately 17.4 kDa.

    AA Sequence

    HPLGKRPCKM QAFRIWDVNQ KTFYMRNNQL VAGYLQESNT KLQEKIDVVP IEPDALFLGL HGRKLCLACV KSGDEIRFQL EAVNITDLSK NKEENKRFTF IRSNSGPTTS FESAACPGWF LCTAQEADRP VSLTNKPKES FMVTKFYLQE DQ

    Tag

    None

    Physical Appearance

    Sterile Filtered White lyophilized (freeze-dried) powder.

    Purity

    > 95% by SDS-PAGE and HPLC analyses.

    Biological Activity

    The ED50 as determined by inhibiting IL-1α-dependent proliferation of murine D10S cells is less than 3.0 μg/mL, corresponding to a specific activity of > 333 IU/mg in the presence of 50 pg/mL rHuIL-1α. Fully biologically active when compared to standard.

    Endotoxin

    1.0 EU per 1μg of the protein by the LAL method.

    Formulation

    Lyophilized from a 0.2 µm filtered concentrated solution in PBS, pH 7.4.

    Reconstitution

    We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20°C. Further dilutions should be made in appropriate buffered solutions.


    Shipping and Storage

     

    The products are shipped with ice pack and can be stored at -20℃ to -80℃ for 1 year.

    Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.

     

    Cautions

     

    1. Avoid repeated freeze-thaw cycles.

    2. For your safety and health, please wear lab coats and disposable gloves for operation.

    3. For research use only!

     

    HB220425